A Phase I Study of STA-9090 in Patients With Advanced Hepatocellular Carcinoma

Trial Profile

A Phase I Study of STA-9090 in Patients With Advanced Hepatocellular Carcinoma

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Sep 2014

At a glance

  • Drugs Ganetespib (Primary)
  • Indications Liver cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Sep 2014 Interim results (n=14) published in the Investigational New Drugs
    • 19 Mar 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
    • 17 Mar 2014 Planned End Date changed from 1 Aug 2012 to 1 Aug 2014, as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top